LOCALLY ADVANCED CARCINOMA
Clinical trials for LOCALLY ADVANCED CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new LOCALLY ADVANCED CARCINOMA trials appear
Sign up with your email to follow new studies for LOCALLY ADVANCED CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug AGX101 targets Hard-to-Treat cancers in early trial
Disease control Recruiting nowThis study tests a new drug called AGX101 in people with advanced solid tumors that have not responded to standard treatments. The drug is given through a vein and aims to shrink or control tumors. The main goals are to find the safest dose and understand side effects. About 80 p…
Matched conditions: LOCALLY ADVANCED CARCINOMA
Phase: PHASE1 • Sponsor: Angiex, Inc. • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
New lattice radiation aims to shrink bulky tumors
Symptom relief Recruiting nowThis study tests a new type of radiation called lattice therapy for people with large, hard-to-treat tumors. The goal is to see if it can shrink tumors better and with fewer side effects than standard radiation. About 37 adults with advanced solid tumors will receive this treatme…
Matched conditions: LOCALLY ADVANCED CARCINOMA
Phase: PHASE2 • Sponsor: University of Cincinnati • Aim: Symptom relief
Last updated May 16, 2026 22:31 UTC